Track Solventum Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Solventum Corporation SOLV Open Solventum Corporation in new tab

76.13 USD
P/E
9.21
EPS
8.17
P/B
2.59
ROE
34.79
Beta
0.66
Target Price
81.08 USD
Solventum Corporation logo

Solventum Corporation

🧾 Earnings Recap – Q1 2026

The stock rose 5.3% following first quarter earnings that outperformed expectations, driven by stronger-than-anticipated organic sales growth, EPS, and margins. Positive momentum across all segments and early success with the recent Acera acquisition propelled investor enthusiasm.

  • Organic sales growth and EPS exceeded company plans, reflecting effective commercial execution and new product launches.
  • Margin performance was better than expected, supported by volume, mix, and ongoing savings initiatives.
  • The acquisition of Acera is off to a promising start, complementing the wound care portfolio and expected to contribute meaningfully during the year.
  • Transformation efforts including ERP cutovers, portfolio optimization, and the $500 million Transform for the Future savings program are progressing well.
  • Board-approved share buybacks (up to $1 billion) signal confidence in the valuation and financial flexibility.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
P/E9.21
EPS8.17
Book Value29.10
Price to Book2.59
Debt/Equity106.46
% Insiders15.044%
Growth
Revenue Growth-0.03%
Earnings Growth-0.91%
Estimates
Forward P/E10.69
Forward EPS7.04
Target Mean Price81.08

DCF Valuation

Tweak assumptions to recompute fair value for Solventum Corporation (SOLV)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Solventum Corporation Logo Solventum Corporation Analysis (SOLV)

United States Healthcare Official Website Stock

Is Solventum Corporation a good investment? Solventum Corporation (SOLV) is currently trading at 76.13 USD. Market analysts have a consensus price target of 81.08 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 9.21. This relatively low multiple may signal that Solventum Corporation is undervalued compared to historical market norms.

Earnings Schedule: Solventum Corporation is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 7.04.

Investor FAQ

Does Solventum Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Solventum Corporation?

Solventum Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 8.17.

Company Profile

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Exchange Ticker
None SOLV

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion